QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
Read MorePosted by CLP Edit Staff | Apr 20, 2026 | Company News, Molecular Diagnostic Analyzers |
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Transfusion & Transplantation Tests |
Modern diagnostic tools are enabling higher-resolution HLA typing for stem cell transplants, supporting faster and more precise donor-recipient matching.
Read MorePosted by CLP Edit Staff | Apr 3, 2026 | Company News |
The five-year agreement with MRIGlobal aims to enhance laboratory readiness and response for public health emergencies.
Read MorePosted by CLP Edit Staff | Apr 3, 2026 | Covid 19 |
PolyBio Research Foundation has launched a $1.35 million program at UCSF to compare and validate diagnostic tests for long COVID, aiming to address the lack of standardized clinical diagnostics in the field.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Company News |
Co-Diagnostics and Arabian Eagle Manufacturing have secured land in Sudair Industrial City, Saudi Arabia, to build a facility for manufacturing molecular diagnostic instruments and assays, supporting regional expansion in the Middle East and North Africa.
Read More